Alejandro Vallejo (A Vallejo)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 19

Top Venues

Viruses

Journal of clinical medicine

HIV medicine

Cancers

Hospital Ramón y Cajal

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Ramón y Cajal Oct 01 2008

Spain

Head of Research group :: Infectious Diseases

Hospital Universitario Virgen del Rocío Apr 01 2000 - Mar 31 2008

Spain

Senior Researcher :: Infectious Diseases

U.S. Food and Drug Administration Sep 01 1999 - Mar 31 2000

United States

Visiting Associate Researcher :: Laboratory of Molecular Virology, DTTD, OBRR, CBER

U.S. Food and Drug Administration Jun 01 1995 - Dec 31 1998

United States

Visiting Fellow_PhD Researcher :: Laboratory of Molecular Virology, DTTD, OBRR, CBER

U.S. Food and Drug Administration Mar 01 1995 - May 31 1995

United States

Guest Worker :: Laboratory of Molecular Virology, DTTD, OBRR, CBER

Instituto de Salud Carlos III Campus de Majadahonda Feb 01 1994 - Jan 31 1995

Spain

Postdoctoral Fellow :: Departamento de Diagnostico y Referencia, Centro Nacional de Biología Celular y Retrovirus (CNBCR)

Instituto de Salud Carlos III Campus de Majadahonda Sep 01 1989 - Jan 31 1994

Spain

PhD Student :: Departamento de Diagnostico y Referencia, Centro Nacional de Biología Celular y Retrovirus (CNBCR)

Education History

Universidad Complutense de Madrid

Spain

PHD :: Immunology

Universidad Autonoma de Madrid Facultad de Ciencias

Spain

BSC

Publications

José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
Alejandro Vallejo, María Abad-Fernández
Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses 15 (4) (2023)
Alejandro Vallejo, María Abad-Fernández
Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses 15 (4) (2023)
Alejandro Vallejo, María Abad-Fernández
Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses 15 (4) (2023)
José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
Cristina Saavedra, Alejandro Vallejo, Federico Longo, Juan José Serrano, María Fernández, María Gion, Elena López-Miranda, Noelia Martínez-Jáñez, Eva Guerra, Jesús Chamorro, Diana Rosero, Héctor Velasco, Adrián Martín, Alfredo Carrato, José Luis Casado, Cortes Salgado Alfonso
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers 15 (7) (2023)
José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
Alejandro Vallejo, María Abad-Fernández
Concluding Remarks for Special Issue HTLV-HIV Co-Infections. Viruses 15 (4) (2023)
José Luis Casado, Johannes Haemmerle, Pilar Vizcarra, Gema Ramirez-Alonso, Andrea Salazar-Tosco, Beatriz Romero-Hernandez, Magdalena Blasco, Mario Rodriguez-Dominguez, Itria G Mirabella, Alejandro Vallejo, Marina Fernandez-Escribano
Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination. Journal of clinical medicine 11 (12) (2022)
José L Casado, Pilar Vizcarra, José M Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, null On Behalf Of The Covid-Irycis Team
Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of clinical medicine 11 (23) (2022)
José L Casado, Pilar Vizcarra, José M Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, null On Behalf Of The Covid-Irycis Team
Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of clinical medicine 11 (23) (2022)
José L Casado, Pilar Vizcarra, José M Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, null On Behalf Of The Covid-Irycis Team
Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of clinical medicine 11 (23) (2022)
María Abad-Fernández, Francisco J Hernández-Walias, María J Ruiz de León, María J Vivancos, María J Pérez-Elías, Ana Moreno, José Luis Casado, Carmen Quereda, Fernando Dronda, Santiago Moreno, Alejandro Vallejo
HTLV-2 Enhances CD8 + T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1. Viruses 14 (11) (2022)
José L Casado, Pilar Vizcarra, José M Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, null On Behalf Of The Covid-Irycis Team
Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of clinical medicine 11 (23) (2022)
José L Casado, Pilar Vizcarra, José M Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, null On Behalf Of The Covid-Irycis Team
Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of clinical medicine 11 (23) (2022)
Alejandro Vallejo, Pilar Vizcarra, Carmen Quereda, Ana Moreno, José Luis Casado, null null
IFN-γ+ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation. European journal of clinical investigation 51 (12) (2021)
José Luis Casado, Elisa Moraga, Pilar Vizcarra, Héctor Velasco, Adrián Martín-Hondarza, Johannes Haemmerle, Sandra Gómez, Carmen Quereda, Alejandro Vallejo
Expansion of CD56 dim CD16 neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients. Viruses 14 (1) (2021)
Francisco J Hernández-Walias, Esther Vázquez, Yolanda Pacheco, José M Rodríguez-Fernández, María J Pérez-Elías, Fernando Dronda, José L Casado, Ana Moreno, José M Hermida, Carmen Quereda, Asunción Hernando, Francisco Tejerina-Picado, Víctor Asensi, María J Galindo, Manuel Leal, Santiago Moreno, Alejandro Vallejo
Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21. Journal of clinical medicine 9 (3) (2020)
Alejandro Vallejo, MdC Molano, M Monsalvo-Hernando, F Hernández-Walias, M Fontecha-Ortega, J L Casado
Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV-1-infected patients: the TRILOBITHE pilot study. HIV medicine 20 (8) (2019)

Alejandro Vallejo.css-eqlu8i{font-size:small;padding-left:4px;} (A Vallejo)

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Vallejo (A Vallejo)